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Phosphate transporters: a tale of two solute carrier families
Abstract
Phosphate is an essential component of life and must be actively transported into cells against its
electrochemical gradient. In vertebrates, two unrelated families of Na+ -dependent P(i) transporters
carry out this task. Remarkably, the two families transport different P(i) species: whereas type II
Na+/P(i) cotransporters (SCL34) prefer divalent HPO(4)(2-), type III Na(+)/P(i) cotransporters (SLC20)
transport monovalent H2PO(4)(-). The SCL34 family comprises both electrogenic and electroneutral
members that are expressed in various epithelia and other polarized cells. Through regulated activity in
apical membranes of the gut and kidney, they maintain body P(i) homeostasis, and in salivary and
mammary glands, liver, and testes they play a role in modulating the P(i) content of luminal fluids. The
two SLC20 family members PiT-1 and PiT-2 are electrogenic and ubiquitously expressed and may serve
a housekeeping role for cell P(i) homeostasis; however, also more specific roles are emerging for these
transporters in, for example, bone mineralization. In this review, we focus on recent advances in the
characterization of the transport kinetics, structure-function relationships, and physiological implications
of having two distinct Na+/P(i) cotransporter families.
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First published June 20, 2007; doi:10.1152/ajprenal.00228.2007.—Phosphate is an
essential component of life and must be actively transported into cells against its
electrochemical gradient. In vertebrates, two unrelated families of Na-dependent
Pi transporters carry out this task. Remarkably, the two families transport different
Pi species: whereas type II Na/Pi cotransporters (SCL34) prefer divalent HPO42,
type III Na/Pi cotransporters (SLC20) transport monovalent H2PO4. The SCL34
family comprises both electrogenic and electroneutral members that are expressed
in various epithelia and other polarized cells. Through regulated activity in apical
membranes of the gut and kidney, they maintain body Pi homeostasis, and in
salivary and mammary glands, liver, and testes they play a role in modulating the
Pi content of luminal fluids. The two SLC20 family members PiT-1 and PiT-2 are
electrogenic and ubiquitously expressed and may serve a housekeeping role for cell
Pi homeostasis; however, also more specific roles are emerging for these transport-
ers in, for example, bone mineralization. In this review, we focus on recent
advances in the characterization of the transport kinetics, structure-function rela-
tionships, and physiological implications of having two distinct Na/Pi cotrans-
porter families.
phosphate; cotransport; electrophysiology; structure-function
PHOSPHORUS IS AN ESSENTIAL element of all living organisms and
fulfills both structural and metabolic roles. Cells obtain phos-
phorus in the form of negatively charged inorganic phosphate
(Pi) from the extracellular environment by means of secondary-
active transport. In vertebrates, Pi transporters use the inwardly
directed electrochemical gradient of Na ions, established by
the Na-K-ATPase, to drive Pi influx. Because defects in Pi
homeostasis result in severe pathologies, it is essential to
understand the transport mechanisms at the molecular level.
In this review, we focus on two unrelated families of
mammalian phosphate transporters with an emphasis on the
current state of knowledge about their structure and mechanis-
tic properties at the molecular level and their physiological
roles. Both are secondary-active, Na-coupled, yet their trans-
port mechanisms are different. Proteins of the solute carrier
family SLC34 (also called type II Na/Pi cotransporters) are the
most extensively characterized in terms of function, structure,
and regulation: its members play essential physiological roles
in the kidney and small intestine for maintaining Pi homeosta-
sis (for a review see Refs. 30 and 70). Proteins belonging to the
SLC20 family (also called type III Na/Pi cotransporters) are
represented by PiT-1 and PiT-2 and were originally identified
as retroviral receptors (19). PiT-1 and PiT-2 are now emerging
as important players in bone Pi metabolism and vascular
calcification. Figure 1 compares the phylogeny of selected
secondary-active Pi cotransport proteins belonging to the type
II and type III families. The mammalian members are classified
according to the human SLC34 and SCL20 gene family no-
menclature.
A third transporter family, SLC17, is sometimes referred to
as the type I Na-dependent Pi transporter family. The first
cloned member of this family (NaPi-1) was first thought to be
a Na-dependent Pi transporter based on Xenopus laevis oo-
cyte expression studies (117) but was later shown to transport
organic anions (14). Another SLC17 protein, BNP1, was also
first classified as a Na/Pi transporter but was later shown to be
a vesicular glutamate transporter (6). As no SLC17 family
members are known to be strict Na/Pi cotransporters, they
will not be reviewed further here (for a review of SLC17 see
Ref. 82).
SLC34: Type II Na/Pi Cotransporter Family
Discovery and tissue distribution. Members of the SLC34
family, designated type II Na/Pi cotransporters (NaPi-II), are
generally found in apical membranes of epithelia and epithe-
lial-like cells. Early transport studies using membrane vesicles
from renal and intestinal epithelial tissue documented second-
ary-active, Na-dependent Pi transport. Further studies used
both cloned transporters and native tissue to characterize the
kinetics and regulation of Na/Pi transport (for a review, see
Ref. 70). SLC34 proteins belong to one of three phylogeneti-
cally distinct branches that are distantly related to the bacterial
Vibrio cholerae Na-dependent Pi transporter (Fig. 1A). The
first family member (NaPi-IIa/SLC34A1) was identified by
expression cloning using X. laevis oocytes (61), and immuno-
histochemistry confirmed its localization at the apical mem-
brane of renal proximal tubular cells. NaPi-IIa protein was also
detected in rat brain (69), osteoclasts (53), and osteoblast-like
cells (59), suggesting a wider expression profile for this “renal”
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isoform. After the discovery of NaPi-IIa, a second isoform
(NaPi-IIb/SLC34A2) was localized to the brush-border mem-
brane of enterocytes and to lung, colon, testes, and liver (42).
The third and newest member (NaPi-IIc/SLC34A3), like NaPi-
IIa, is apically expressed in the renal proximal tubule (60, 89).
The amino acid sequences of all three SLC34 proteins are
similar in the predicted transmembrane-spanning regions but
diverge in the NH2 and COOH termini and a prominent
extracellular loop that separates the protein into two halves (see
Topology and structure-function studies).
Physiological role and pathophysiology. The expression and
regulation of SLC34 proteins in their intestinal and renal
context have been extensively studied because these organs
represent, respectively, the principle entry and exit points for
Pi. Renal regulation of NaPi-IIa has been the subject of several
recent reviews (30, 66, 70, 98, 100, 116) and is briefly dis-
cussed here. The critical role of NaPi-IIa for Pi homeostasis is
underscored by the hyperphosphaturia phenotype documented
in the NaPi-IIa knockout mouse (5). Dysregulation of NaPi-IIa
causes Pi deficiency disorders, such as X-linked hypophos-
phatemia (XLH) and autosomal-dominant hypophosphatemic
rickets (ADHR) (reviewed in Ref. 98). However, no mutation
in the NaPi-IIa gene NPT2a has yet been unequivocally linked
to human disease. Prie´ et al. (78) reported that heterozygous
mutations in NaPi-IIa were responsible for hypophosphatemia
leading to nephrolithiasis or osteoporosis. They reported that
the mutations caused a decrease in apparent Pi affinity or
impaired targeting to the plasma membrane and induced a
dominant negative effect on wild-type transporter function
when expressed in X. laevis oocytes. In contrast, extensive
investigation of the same mutants in our laboratory found no
evidence for such effects (111). The present consensus is that
the mutations alone are not responsible for the clinical disor-
ders in the patients (98). Recently, a second study of NaPi-IIa
genetic polymorphisms as a possible cause of hyperphospha-
turia and hypercalciuria (55) reported no significantly altered
kinetics of the mutant NaPi-IIa transporters when expressed in
X. laevis oocytes.
In mice with homozygous deletion of the Npt2a gene,30%
Pi reabsorption remains in the kidney. This fraction can most
likely be attributed to NaPi-IIc, which was originally described
as a growth-related transporter in weaning rats (89). Recent
publications describe mutations of the NPT2c gene in humans
as being responsible for hereditary hypophosphatemic rickets
with hypercalciuria (HHRH) (7, 47, 57). The effect of muta-
tions on the NaPi-IIc protein identified in patients diagnosed
with HHRH is currently undergoing in vitro investigation (C.
Bergwitz, personal communication). Interestingly, two of the
mutants have amino acid substitutions that correspond to func-
tionally important sites identified in the context of electroge-
nicity (Ref. 3 and see below). Moreover, the marked patho-
physiological consequences of NaPi-IIc mutations in human
subjects suggest a more important role for this protein than
initially suspected from animal data (89).
Whereas the physiological roles of SLC34 proteins, partic-
ularly in the kidney, are well characterized, it is obvious that
future work must also focus on other organs. For example,
regulated Pi transport is crucial for the formation of mineral-
ized bone. NaPi-IIa is expressed in osteoclasts (37, 53) and
chondrocytes (62), whereas osteoblasts express both NaPi-IIa
and NaPi-IIb (59). NaPi-IIb is responsible for transcellular Pi
absorption in the small intestine and is regulated by dietary Pi
(80) and metabolic acidosis (91). In the liver, NaPi-IIb is
involved in the reabsorption of Pi from primary hepatic bile
(35). In salivary glands, NaPi-IIb is involved in secreting Pi
into saliva, where a high Pi content is important for reminer-
alization of dental enamel (45). In the brain, NaPi-IIa may play
a role in central nervous system regulation of Pi homeostasis
(44, 69). Improper NaPi-IIb expression in the epididymis is
implicated as a possible causative agent in a mouse model of
male infertility (120). NaPi-IIb is expressed in alveolar type II
cells (101), and mutations in NaPi-IIb have recently been
associated with pulmonary microlithiasis (20, 46). In mice,
NaPi-IIb is expressed apically in lactating mammary gland but
not in virgin mice (67), which suggests a role for NaPi-IIb in
milk secretion. Dysfunction of NaPi-IIb may also be involved
Fig. 1. Phylogenetic tree of SLC34 and SLC20 cotransporter families. Amino acid sequences were aligned using ClustalW. GenBank accession numbers are
listed in parenthesis. A: SLC34 (type II Na/Pi transporters). The following sequences were used: mouse NaPi-IIb (AAC80007), rat NaPi-IIb (NP_445832),
human NaPi-IIb (AAF31328), Xenopus laevis NaPi-IIb (AAF21135), human NaPi-IIa (AAA36354), flounder NaPi-IIb (AAB16821), mouse NaPi-IIc
(NP_543130), rat NaPi-IIc (NP_647554), human NaPi-IIc (NP_543153), mouse NaPi-IIa (AAC52361), rat NaPi-IIa (NP_037162), human NaPi-IIa
(AAA36354), and Vibrio cholerae NaPi-II (230325). B: SLC20 (type III Na/Pi transporters). The following sequences were used: human PiT-1 (NM_005415),
mouse PiT-1 (AAB31458), rat PiT-1 (NM_031148), X. laevis PiT-1 (AAH59957), Danio rerio PiT-1 (NM_213179), mouse PiT-2 (NM_011394), rat PiT-2
(NM_017223), human PiT-2 (NM_006749), X. laevis PiT-2 (BC084098), Arabidopsis thaliana Pht2;1 (NM_113565), Medicago truncatula Pht2;1 (AAN46087),
Plasmodium falciparum PfPiT (AJ580003), Neurospora crassa Pho-4 (XM_954396), Escherichia coli PitA (NC_002655), and E. coli PitB (NC_000913).
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in the formation of microliths in other organs where the
transporter is expressed. Of particular significance is that
mammary tissue, microcalcifications containing calcium phos-
phate, are more commonly associated with malignancy than
ones without a phosphate component (34).
Finally, although specific studies are still lacking, it is likely
that the newcomer, NaPi-IIc, is not exclusively expressed in the
kidney, as originally suggested (71, 89). A query of published
microarray data deposited in the Gene Expression Omnibus
(GEO) database reveals that the transcript for NaPi-IIc is abundant
in several tissues, such as brain, breast, liver, and blood (L. V.
Virkki, unpublished observations). Like for NaPi-IIa and NaPi-
IIb, it is expected that future studies will reveal important roles for
NaPi-IIc also in these extrarenal locations.
Transport kinetics. The transport kinetics of SLC34 proteins
have been extensively studied (for a review, see Refs. 30 and
31) by means of heterologous expression in X. laevis oocytes.
In essence, all three SLC34 proteins exhibit a strict dependence
on external Na as the driving substrate, with an apparent
affinity for Na of 50 mM, a preference for divalent Pi
(HPO42) as the driven substrate with an apparent affinity of
0.1 mM, and cotransport activity inhibitable by phosphono-
formic acid (PFA) (15, 119; G. Stange, I. C. Forster, unpub-
lished observations). These common features indicate that the
basic transport mechanism is the same for all SLC34 members.
Nevertheless, two important, interrelated differences in the
kinetic properties have been documented, namely, electroge-
nicity and stoichiometry. NaPi-IIa and NaPi-IIb are electro-
genic, and transport Pi with a 3:1 Na:HPO42 stoichiometry,
whereas NaPi-IIc is electroneutral and operates with a 2:1
Na:HPO42 stoichiometry.
ELECTROGENIC ISOFORMS NaPi-IIa/b. Tracer uptake assays on
brush-border membrane vesicles first suggested that Na-coupled
Pi cotransport was electrogenic (12). However, this property
could not be unequivocally defined without determination of
the Na-Pi stoichiometry, identification of the preferred Pi
species, and transmembrane electrical measurements. More
direct evidence for electrogenic Na-dependent Pi cotransport
was obtained by recording the transmembrane potential of
isolated, perfused proximal tubule cells (88), later confirmed
by heterologous expression of cloned NaPi-IIa in X. laevis
oocytes (13, 39). These studies established that Pi induced an
inward current in the presence of external Na when the cell
was hyperpolarized (Fig. 2, A and B). By assuming that the
Pi-induced change in cell holding current under voltage clamp
(IPi) directly reflected the cotransport activity, it was inferred
that NaPi-IIa operated with a 3:1 Na:Pi stoichiometry at
physiological pH (7.4), where divalent Pi predominates. Nev-
ertheless, there was uncertainty about the selectivity of the
transporter for divalent vs. monovalent Pi and the influence of
external pH, which itself determines the availability of the Pi
species. Simultaneous measurement of net charge transfer and
substrate flux (32, 110) and surface pH measurements (81) (see
Fig. 6C) on the same oocyte have resolved this issue unam-
Fig. 2. Basic transport properties of SLC34 proteins ex-
pressed in X. laevis oocytes. A: original current recordings
from an oocyte expressing flounder NaPi-IIb in solution
containing 100 mM Na (left) and 100 mM Na 1 mM Pi
(right). The voltage was stepped from 160 to 80 mV in
40-mV increments. B: characteristic current-voltage curve
for Pi-dependent currents (IPi) with different driving cations
(at 100 mM) for an oocyte expressing the flounder NaPi-IIb
isoform. Each data point is the difference between the
oocyte holding current at the indicated membrane potential
with and without 1 mM Pi (pH 7.4). No significant inward
current is recorded when Na is replaced with choline or
Li. C: pre-steady-state relaxations recorded from an oo-
cyte expressing the flounder NaPi-IIb isoform evoked by
voltage steps from 60 mV to voltages in range 180
to 80 mV. Relaxations are partially suppressed in pres-
ence of 1 mM Pi, and in 100 mM cholineCl, relaxations are
still resolvable. These are thought to arise from molecular
rearrangements within the NaPi-IIb protein. D: determina-
tion of the stoichiometry of SLC34 proteins. Top: individ-
ual oocytes expressing the electrogenic rat NaPi-IIa isoform
were voltage clamped, and the charge (Q) and amount of
tracer substrate (32Pi or 22Na) taken up was assayed. The
ratio Q:Pi (filled symbols) is 1:1, the ratio Q:Na (open
symbols) is 1:3. These data indicate that the Na:Pi stoi-
chiometry is 3:1, with one net charge translocated per Pi.
(redrawn and modified from Ref. 32). The Q:Pi ratio re-
mains unchanged at lower pH, indicating that divalent Pi is
the preferred species (not shown). Bottom: for electroneu-
tral NaPi-IIc, data indicate a ratio Na:Pi of 2:1, consistent
with a preference for divalent Pi and 2 Na ions translo-
cated per cycle (redrawn and modified from Ref. 3).
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biguously. Moreover, these studies confirmed that NaPi-IIa and
NaPi-IIb preferentially transport divalent Pi, independently of
the external pH (Fig. 2D) (32). External acidification affects
both the intrinsic voltage dependence and Na interaction of
electrogenic NaPi-II cotransporters (29, 110), which results in
a decrease in maximum transport rate and reduced apparent
affinity for divalent Pi (see Fig. 6A).
The electrogenicity of NaPi-IIa/b implies that net charge is
transported across the membrane. Moreover, IPi shows rate-
limiting, voltage-independent behavior at hyperpolarizing and
depolarizing extremes (Fig. 2B). This indicates that the trans-
port cycle involves both voltage-dependent and voltage-inde-
pendent partial reactions. The former have been identified from
analysis of pre-steady-state charge movements evoked by volt-
age steps (for a review, see Ref. 31) (Fig. 2C). For carrier
proteins like NaPi-IIa/b, the charge movements in the absence
of substrate are proposed to reflect two events: 1) a major
reorientation of the carrier that alternately exposes the substrate
binding sites to the external or internal medium and 2) move-
ment of Na ions from the external milieu to and from their
binding site(s) within the transmembrane field (30, 31).
The transport turnover rate of NaPi-IIa/b can be estimated
from pre-steady-state and steady-state data. Rates in the range
4–10 s1 at 20°C are predicted (33) and should be about
threefold faster under normal physiological conditions, when
the temperature dependence of the kinetics is taken into ac-
count (2). Combining steady-state and pre-steady-state data has
led to the proposal of an ordered kinetic scheme for the
NaPi-IIa/b transport cycle (28, 33, 110, 113) (see Fig. 7A).
Voltage dependence is conferred by the empty carrier and one
Na binding transition. Similar schemes have been proposed
for other Na-coupled solute carriers [e.g., Na/glucose trans-
porter SGLT1 (76) and Na/iodide transporter NIS (23)] and
are consistent with the alternating access mechanism for trans-
membrane transport. Previously, a single Na ion was as-
sumed to interact with the protein before Pi binding (28). The
model was revised to incorporate new evidence obtained by
simultaneous whole-oocyte electrophysiology and time-re-
solved fluorescence of a site-directed fluorescent label (voltage
clamp fluorometry; VCF) (113) that identified an additional,
electrically silent, Na binding transition preceding Pi binding.
ELECTRONEUTRAL NaPi-IIc. The electroneutrality of NaPi-IIc
(71, 89) comes as a surprising contrast to the voltage depen-
dence of NaPi-IIa/b, and this fact emphasizes how small
differences in amino acid composition can drastically alter
specific kinetic properties. Oocytes expressing functional
NaPi-IIc (confirmed by 32Pi uptake) are electrically silent (3,
89). For other kinetic properties, such as apparent substrate
Fig. 3. Topological model for rat NaPi-IIa. Transmembrane domains were assigned according to Ref. 79. The model was drawn with the aid of TOPO2 software
(http://www.sacs.ucsf.edu/TOPO/topo.html). Enlarged symbols indicate sites of significant structure-function importance. Pink, identical residues in the NH2-
and COOH-terminal repeated regions (see text); green, sites that are, when mutated to a cysteine, accessible to the extracellular milieu; blue, sites that are, when
mutated to a cysteine, accessible to the intracellular milieu; red, sites important for electrogenicity; orange, sites important for regulation and targeting; yellow,
sites of naturally occurring SLC34A1 (human NaPi-IIa) mutants shown not to affect function; purple, equivalent sites of reported naturally occurring SLC34A3
(human NaPi-IIc) mutations. An essential disulfide bridge in the large extracellular loop is indicated (dashed line). Light blue regions are reentrant loops,
proposed to form a putative transport pathway through the protein. Two N-glycosylation sites have been identified in the large extracellular loop.
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affinity and pH dependence, NaPi-IIc is indistinguishable from
its electrogenic cousins. Moreover, its Na:Pi stoichiometry of
2:1 is consistent with a preference for divalent Pi and is thus
similar to NaPi-IIa and IIb (Fig. 2D) (3). Thus NaPi-IIc lacks
one of the three Na interaction steps proposed for NaPi-IIa/b.
Simulations of the transport steady-state and pre-steady-state
kinetics also support the notion that the first Na interaction
may be electrogenic, followed by an electroneutral or weakly
electrogenic second Na interaction (see Fig. 7A). The latter
would correspond to the first Na interaction for NaPi-IIc
(I. C. Forster, unpublished observations).
Topology and structure-function studies. The current topo-
logical model of SLC34 has been developed mainly using
cysteine scanning and in vitro transcription/translation on
NaPi-IIa but is probably applicable also to NaPi-IIb and NaPi-
IIc (for a review, see Refs. 30 and 31). The model comprises 12
transmembrane-spanning domains, intracellularly located NH2
and COOH termini, and two N-glycosylation sites located in a
large extracellular loop (Fig. 3). NaPi-IIa is a functional mono-
mer (54), and this is also assumed to be the case for NaPi-IIb
and NaPi-IIc. There is evidence for in vivo dimerization of
SLC34 proteins from dual tagging and split ubiquitin approaches
and freeze fracture studies on X. laevis oocytes expressing the
flounder NaPi-IIb isoform (30). At present, the tertiary structure of
the monomers is unknown; however, at least one disulfide bridge
is essential for stable expression of NaPi-IIa in the oocyte mem-
brane (Fig. 3). This may play a role in defining the spatial
arrangement of the transmembrane domains. Sites specific to
expression and residues critical for regulation have been identified
on the intracellular side (Fig. 3): the KR motif confers PTH
sensitivity, and a TRL/THL motif, which is a PDZ binding motif,
found in the COOH-terminal tail is essential for membrane ex-
pression (for a detailed review, see Refs. 30 and 41).
An important structural feature of the NaPi-II primary sequence
are the two “repeat” regions in the NH2- and COOH-terminal
halves of the protein. These repeats are preserved in all NaPi-IIa/
b/c transporters as well as in homologs from V. cholerae and
Caenorhabditis elegans (116), which strongly suggests that this
conserved motif plays an essential functional role. The current
secondary topology of NaPi-IIa depicts these regions as incorpo-
rating two pairs of -helices. Further studies have demonstrated
that they may form two opposed reentrant loops that create
opposed vestibules, allowing substrate access from either side of
the membrane (79, 112).
Recent VCF data also support the notion that the two halves of
the NaPi-IIb protein move in a complementary manner during the
transport cycle (112). The dependence of fluorescence on sub-
strate and membrane potential, recorded from four labeled sites
located in externally accessible linker regions, indicated that
complementary conformational changes occur in the two halves
of the protein during the transport cycle. VCF studies offer a
real-time, albeit indirect, view of molecular rearrangements that
occur at specific sites during substrate interaction and transloca-
tion.
Finally, the difference in electrogenicity between NaPi-IIa/b
and NaPi-IIc was exploited to identify a charged residue that is
most likely implicated in Na binding and electrogenicity of
NaPi-IIa/b (3) (Fig. 3). A sequence alignment revealed three
clusters of residues that differed between the NaPi-IIa/b and
NaPi-IIc isoforms. One cluster contained an aspartic acid (Asp-
224 in human NaPi-IIa) conserved in all electrogenic isoforms but
replaced by a glycine (Gly-196 in human NaPi-IIc). When three
amino acids in NaPi-IIc (including Gly-196) were replaced with
the corresponding amino acids of NaPi-IIa/b, electrogenic Pi
transport was conferred to NaPi-IIc. Consistent with expectations,
pre-steady-state charge movements were also detected. Signifi-
Fig. 4. Basic transport properties of SLC20 proteins ex-
pressed in X. laevis oocytes. A: original current recordings
from an oocyte expressing X. laevis PiT-1 in solution
containing 100 mM Na (left) and 100 mM Na and 1 mM
Pi (right). The voltage was stepped from 160 to 40 mV
in 20-mV increments. B: characteristic current-voltage
curve IPi derived from data in A with different driving
cations (at 100 mM) for an oocyte expressing the X. laevis
PiT-1 isoform. No significant inward current is recorded
when Na is replaced with choline, whereas in Li currents
are reduced by 85% at negative membrane potentials,
compared with Na. C: data for the determination of the
Q:Pi stoichiometry of X. laevis PiT-1. Individual oocytes
expressing XlPiT-1 were voltage clamped, and the charge
(Q) and amount of Pi translocated were assayed by inte-
grating the Pi-induced current and by using 32Pi as a tracer,
respectively. The ratio Q:Pi was 1:1 at both pHs assayed
(7.4 and 6.2). D: data for the determination of the Na:Pi
stoichiometry of X. laevis PiT-1. Dual uptake assay with
22Na and 32Pi as tracers performed at pH 6.2 and 7.4
suggests a 2:1 Na:Pi stoichiometry for SLC20. Since the
Q:Pi and Na:Pi ratios were the same at both pH, mono-
valent Pi should be the preferred species. C and D were
redrawn and modified from Ref. 81.
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cantly, the Na:Pi stoichiometry of the electrogenic mutant NaPi-
IIc is 3:1; however, its apparent substrate affinities and voltage
dependence are altered compared with wild-type transporters.
Furthermore, replacing the conserved Asp-224 in NaPi-IIa with
NaPi-IIc’s glycine resulted in electroneutral Pi transport, thus
confirming that Asp-224 is necessary for a 3:1 Na:Pi stoichiom-
etry (109).
SLC20: Type III Na/Pi Cotransporter Family
Discovery. Type III Na/Pi cotransporters were first identi-
fied as receptors for retroviruses, which may enter a cell
following a specific interaction with the receptor. The first hint
that the retroviral receptor Glvr-1, which renders cells suscep-
tible to infection by gibbon ape leukemia virus, is a phosphate
transporter was revealed by its homology to a phosphate
permease from Neurospora crassa, a filamentous fungi (48). A
related protein, which renders cells susceptible to infection by
amphotropic murine retrovirus (Ram-1) was subsequently
identified (65, 104). Experimental evidence showing that ret-
roviral receptors Glvr-1 and Ram-1 are electrogenic Na/Pi
symporters then followed (51, 52, 72), and the receptors were
renamed PiT-1 and PiT-2, respectively.
PiT-1- and PiT-2-related proteins are present in all phyla
(Fig. 1B). In prokaryotes and in plants, Pi transport is coupled
to the H gradient (21, 38, 103), whereas in animals and fungi,
the driving cation is Na (19, 64, 106). In the bacterium
Bacillus subtilis, the related protein CysP mediates H/SO42
cotransport (63), but so far no other PiT family member has
been shown to transport SO42.
Physiological role and pathophysiology. PiT proteins have a
broad tissue distribution, and it was proposed that they serve a
housekeeping function in cells. At the mRNA level, PiT-1 and
PiT-2 are ubiquitously but differentially expressed in different
tissues (4, 97, 102). However, recently more specific roles for
PiT proteins in various physiological and pathophysiological
processes have emerged. For example, PiT-mediated Pi trans-
port appears to play an important role in providing Pi for the
formation of mineralized bone (16, 36, 75, 93, 121, 123).
Accordingly, it has been shown that in cultured bone-derived
cells Pi transport and PiT mRNA levels are regulated by
various factors, such as Pi, epinephrine, platelet-derived
growth factor (PDGF), insulin-like growth factor (IGF-1), and
basic fibroblast growth factor (bFGF) in osteoblast-like cells
(18, 94, 95, 122, 123) and in chondrogenic cells by transform-
ing growth factor- (TGF-) (74) as well as Pi levels (114).
Interestingly, Pi regulation of PiT-2 transport function may
result from posttranslational modification of the transporter
(83), and Pi may regulate the formation of PiT-2 oligomers,
implying that PiT proteins play a role in phosphate sensing
(84). In addition to playing a role in normal calcification, PiT
Fig. 5. Topological model for human PiT-2. Transmembrane domains were assigned according to Ref. 86. The model was drawn with the aid of TOPO2 software
(http://www.sacs.ucsf.edu/TOPO/topo.html). Residues important to PiT function investigated by mutagenesis (10, 11, 85) are indicated. Light blue, PD1131
homology domains identified in Ref. 86; pink, region that can be removed without compromising retroviral receptor function of PiT-2 (9). Red, acidic residues
important for transport function (D28, E55, D506, E575) and not critical for transport function (E68, D78, E91). The protein is N-glycosylated at Asp-81.
Numbers designate predicted transmembrane domains and loops (italic) referred to in the text.
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proteins were recently implicated in pathological processes,
such as hyperphosphatemia-induced calcification of vascular
tissue (50, 56, 68) and osteoarthritis (17).
Regulation of PiT function has also been shown for ex-
traskeletal cells and tissues. For example, in human embryonic
kidney cells (HEK-293), PiT-1-mediated Pi transport is regu-
lated by Pi levels and PTH (25). In rat parathyroid glands,
PiT-1 mRNA levels are regulated by plasma vitamin D and Pi
levels (97).
Unfortunately, at the protein level only limited data are
available regarding the tissue and subcellular distribution of
PiT-1 and PiT-2. Khadeer et al. (53) detected PiT-1 mRNA in
osteoclasts and macrophages and showed that transfected pro-
tein localizes to the basolateral membrane. This subcellular
localization was similar to that of NaPi-IIa, indicating an
involvement of both NaPi-IIa and PiT-1 in Pi transport in
bone-resorbing osteoclasts. PiT proteins may also play a role in
Pi transport in the distal segments of the kidney. Tenenhouse
et al. (99) showed that both PiT-1 and PiT-2 mRNAs are
present in immortalized mouse distal convoluted tubule
(MDCT) cells and that the pH dependence of Pi transport is
consistent with PiT-mediated transport.
Finally, PiT proteins may play an important role in basolat-
eral as well as apical Pi uptake in polarized epithelia. In the
liver, PiT-1 and PiT-2 localize to the basolateral membrane in
hepatocytes (35), whereas in airway epithelial cells PiT-2 is
expressed both apically and basolaterally (115). In Pi-secreting
glands, such as the lactating mammary gland (90) and ruminant
parotid gland (105), PiT proteins may provide basolateral
uptake of Pi from the blood for subsequent secretion into the
lumen through an as yet unknown mechanism.
Recently, Saliba et al. (87) showed that the malaria parasite
Plasmodium falciparum expresses a PiT protein (PfPiT) in its
plasma membrane that is instrumental for supplying Pi to the
intraerythrocytic parasite. PfPiT-mediated Pi transport is ener-
gized by the Na gradient and, because infection causes a
gradual increase in intracellular Na, there is adequate driving
force for Pi uptake via PfPiT.
Transport kinetics. After Kavanaugh et al. (52) in 1994
showed that the retroviral receptors Glvr-1 and Ram-1 are
electrogenic Na/Pi cotransporters, very limited characteriza-
tion of the transport kinetics of either PiT-1 or PiT-2 has been
reported (4, 8, 97, 99, 107). None of these more recent studies
used electrophysiology, which is essential for the kinetic char-
acterization of electrogenic transporters. Furthermore, these
studies suffered from low transport activities, possibly because
of low expression. To close this knowledge gap, we recently
characterized PiT transport kinetics using the X. laevis oocyte
expression system and two-electrode voltage clamp as well as
radiotracer uptake (81). We performed most of our kinetic
studies on a X. laevis PiT-1 clone (XlPiT-1), which gave much
Fig. 6. pH and transport characteristics of
SLC34 and SLC20 compared. A: Pi and HPO42
apparent affinities (K0.5) and maximum trans-
port rate (Vmax) measured in oocytes expressing
human NaPi-IIa as a function of pH. Vmax data
were fitted with the Hill equation, yielding an
apparent inhibitory constant Ki for H of
400  40 nM with a Hill coefficient of 2.1 
0.6 (110). B: Pi and H2PO4 K0.5 and Vmax
measured in oocytes expressing XlPiT as a
function of pH. C: surface pH measurements in
noninjected oocytes and in oocytes expressing
flounder NaPi-IIb or XlPiT. Application of 1
mM Pi is indicated by a filled bar. ON and OFF
refers to the pH electrode position: either
pressed against the oocyte or in the bath, re-
spectively. D: summary of surface pH changes
induced by Pi application in experiments simi-
lar to C. pH changes in oocytes expressing
either NaPi-IIb or XlPiT are significantly dif-
ferent from uninjected oocytes. Data in B–D are
redrawn from Ref. 81.
Table 1. Properties of Na/Pi cotransporters
Substrates Stoichiometry Na:Pi Electrogenic Concentrating Capacity PFA Block Mutations Associated with Disease
NaPi-IIa Na, HPO42, Arsenate 3:1 Yes 10,000 Yes
NaPi-IIb Na, HPO42, Arsenate 3:1 Yes 10,000 Yes Pulmonary Alveolar Microlithiasis (20, 46)
NaPi-IIc Na, HPO42, Arsenate 2:1 No 100 Yes HHRH (7, 47, 57)
PiT-1 Na, H2PO4, Li, Arsenate 2:1 Yes 1,000 No
PiT-2 Na, H2PO4, Li, Arsenate 2:1 Yes 1,000 No
Concentration capacity is shown for a membrane potential of 60 mV and a 10-fold Na gradient (outside-inside). HHRH, hereditary hypophosphatemic
rickets with hypercalciuria. References are shown in parentheses.
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higher Pi transport in X. laevis oocytes than mammalian PiT-1
or PiT-2.
In XlPiT-1-expressing oocytes, applying Pi in the presence
of Na induces an inward current (IPi) with no reversal poten-
tial over the voltage range applicable to oocytes (180 to 80
mV; Fig. 4B). PiT-dependent Pi transport is Na dependent,
but Li supports Pi transport to a small extent (11, 81, 107).
Interestingly, two studies have shown that in the absence of
Na, lowering pH from 7.5 to 6.0 induced significant Pi uptake
in oocytes expressing PiT-2, indicating that in this isoform H
could substitute for Na (8, 107). Li may support cotransport
in some Na-driven transporters, such as the Na/dicarboxy-
late transporter (73), Na-driven Cl/HCO3 exchanger (108),
and the Na/glucose cotransporter (43), but not in type II
Na/Pi cotransporters, although Li may interact with their
transport cycle (112, 113).
Another difference between type II and type III Na/Pi
cotransporters is that whereas Na-dependent pre-steady-state
currents are readily measured in oocytes expressing NaPi-IIa or
NaPi-IIb in the absence of Pi, analogous charge movement in
oocytes expressing XlPiT-1 were undetectable, although IPi
was of similar magnitude as in NaPi-II-expressing cells (Fig. 4,
A and B). PiT-1 pre-steady-state relaxations may be too fast to
detect and remain buried in the capacitive transient of the
oocyte or indicate that other models of electrogenic transport
should be considered.
Neither PiT-1 nor PiT-2 transports sulfate; however, the
toxic phosphate mimetic arsenate interacts with PiT-1 (4, 52,
81). Arsenate competes with Pi and reduces Pi transport in both
PiT-1 and PiT-2 and also induces inward currents similar to Pi
but has a lower affinity (4, 81). The effects of arsenate are very
similar in type II Na/Pi cotransporters (15, 39).
The transport stoichiometry of XlPiT-1 was determined by
combining electrophysiology and 22Na and 32Pi tracer uptake
experiments. PiT-1 transports two Na ions for each monova-
lent H2PO4 with one positive charge (81) (Fig. 4, C and D).
We confirmed that H2PO4 is preferred over HPO42 in PiT-1,
using surface pH measurements. Because removal of either
H2PO4 or HPO42 from the medium by a transporter causes a
shift in H2PO4:HPO42 equilibrium, a measurable change in
H concentration occurs. For oocytes expressing PiT-1, appli-
cation of 1 mM Pi caused alkalinization at the oocyte surface,
consistent with transport of H2PO4 into the cell (see Fig. 6C).
In contrast, expressing the type II Na/Pi cotransporter resulted
in acidification, in agreement with transport of HPO42 (see
Fig. 6, C and D).
PiT proteins are less sensitive to H than members of the
SLC34 family. The maximum attainable Pi transport rate
(Vmax) is not influenced by changes in pH between 5.0 and 7.4
(see Fig. 6B). Whereas the apparent affinity for total Pi
shows a biphasic change with pH with a minimum pH 6.8,
the apparent affinity for the preferred substrate HPO42 is
reasonably constant between pH 6.2 and 8.0 and decreases
at more acidic pH. In contrast, Pi transport mediated by
members of the type II cotransporter family (see Fig. 6A) is
strongly reduced at acidic pH due to the inhibitory effect of
protons on the transport cycle as well as reduced availability of
divalent HPO42 (29, 110). Thus PiT proteins can maintain high
Pi transport capacity even at the highly acidic pH of 5.0, where
SLC34 transporters no longer function.
Presently, there are no known inhibitors of PiT-mediated Pi
transport. Phosphonoformic acid (PFA) is a well-known inhib-
itor of Na-dependent Pi transport mediated by type II Na/Pi
cotransporters (15, 96), but it does not inhibit PiT-1 or PiT-2
when expressed in oocytes (81). Although inhibition by PFA of
PiT-mediated Pi transport has been reported (4, 99, 107), only
high concentrations (10 mM) were effective and membrane
potential was not controlled, so the effect of PFA may have
been nonspecific. In addition, it has been reported that PFA
blocks Pi-induced calcification in smooth muscle cells (50, 56)
as well as matrix calcification in osteoblast-like cells (93) and
osteoblast subcultures (121). As PFA does not block PiT-
mediated Pi transport, it is likely that this effect is due to the
ability of phosphonates and bisphosphonates to inhibit calcium
crystal formation (26, 27, 118). Alternatively, a member of the
PFA-sensitive type II Na/Pi cotransporter family may play a
role in the calcification process.
Fig. 7. Kinetic schemes for SLC34 (A) and SLC20 (B) proteins based on the
interpretation of experimental data. Numbers indicate conformational states of
the protein. Light grey indicates transitions for intracellularly facing confor-
mational changes that are uncharacterized. A: electrogenic SLC34 proteins
(NaPi-IIa/b) obtain their electrogenicity from the empty carrier reorientation
(8-1) and binding of 1 Na ion within the transmembrane electric field (1-2a).
Li can also interact with the protein when in state 1 and possibly prevents
subsequent transitions from occurring. An electroneutral second Na binding
step precedes the Pi interaction (2a-2b). The fully loaded carrier is electroneu-
tral (intrinsic carrier charge 3Na H2PO4) and the reorientation (4-5) is
proposed to be rate limiting. Phosphonoformic acid (PFA) competes with Pi
binding. Protons interact with the voltage-dependent transitions and final Na
binding. For electroneutral NaPi-IIc, the net mobile charge of the empty carrier
is 0 and the 1st Na interaction is absent. These transitions are replaced by an
electroneutral transition (2a-8a). For NaPi-IIa/b, a Na-leak pathway (2a-8a),
active in the absence of Pi, has also been characterized (2, 28, 29). This is
undetectable in NaPi-IIc. The depicted mirror symmetries are speculative, and
access to the intracellular milieu will be necessary to identify and characterize
the transitions between the hypothesized internally oriented conformations.
B: for PiT-1 proteins, experimental evidence suggests a mixed ordered/random
binding scheme. As no pre-steady-state charge movement has so far been
detected, we are unable to identify voltage-dependent transitions and tenta-
tively assign the final reorientation of the fully loaded carrier (4-5, net
charge 1) as the voltage-dependent transition.
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Topology. The topology of PiT proteins has been partially
determined (Fig. 5). Topology prediction algorithms usually
report 9 or 11 transmembrane domains for PiT-1 and PiT-2,
which would place the NH2 and COOH termini on opposite
sides of the membrane. However, tags inserted at the NH2 and
COOH termini are accessible from the external side, indicating
that both termini are extracellular (24, 83, 86). A homological
search (86) revealed the presence of a conserved domain in PiT
proteins that is duplicated in most family members (light blue
shading in Fig. 5). Reasoning that such duplicated sequences
probably have similar but inverted topologies, Salau¨n et al.
(86) proposed a secondary structure comprising extracellular
NH2 and COOH termini and 12 putative transmembrane do-
mains (Fig. 5). They confirmed that loop 2 is extracellular by
showing that PiT-2 is N-glycosylated at Asp-81. The intracel-
lular localization of the large loop 7 was confirmed using an
antibody raised against it (18). Similar topologies have been
suggested for the malaria parasite transporter PfPiT (87) and
for the related H/Pi transporter Pht2;1 from the plant Arabi-
dopsis (21). Interestingly, the plant protein is lacking the large
intracellular loop present in animal PiTs. Furthermore, Bottger
and Pedersen (9) showed that PiT2 retains its retroviral recep-
tor function after deletion of loop 7 as well as transmembrane
domains 6–7 (pink shading in Fig. 5). They did not investigate
the transport function of their truncated protein, and thus it is
unknown whether the large loop is essential for substrate
transport.
The ability of a retrovirus to infect cells via its receptor has
been used extensively to investigate which amino acids are
crucial for infection with different viruses and thus also serves
as a tool for probing the secondary structure of PiTs. Most of
the attention has been directed towards loop 8 (Fig. 5). This
shows large sequence variability between different species, and
it appears to play a role in determining virus binding (22, 49,
77). Therefore, it is likely to be extracellular, although an
opposing view has also been presented (24). The issue has been
extensively discussed (8) in favor of the model proposed by
Salaun et al. (86).
So far, only a few features of PiT topology have been
experimentally confirmed, such as the location of the termini
and loops 2 and 7. Salaun et al. (86) conducted in vitro
translation experiments using PiT-2 constructs truncated at the
COOH terminus. These data support the extracellular location
of the four extracellular loops and the COOH terminus,
whereas the other loops are intracellular. However, it is clear
that further experiments are needed to establish a definitive
membrane topology for PiT-1 and PiT-2, for example, by
epitope tagging of putative loops or probing the accessibility of
introduced cysteines to membrane-impermeant reagents, as
done for the SLC34 protein.
Summary
In vertebrates, the two unrelated solute transport families
SLC20 and SLC34 mediate Na/Pi cotransport through differ-
ent molecular mechanisms. Their main functional properties
are summarized in Table 1. It is remarkable that the two
families have evolved a preference for one of the two Pi species
that are most abundant at physiological pH, and thus both
monovalent and divalent Pi species have their own dedicated
carriers. Whether this functional difference between the two
families has a strong impact on physiology is unclear. Note that
transport of either Pi species across a membrane will affect pH,
since it shifts the equilibrium of the reaction H2PO4 HPO42 
H. An additional consequence is that the two families differ
in their optimum pH range, overlapping around the pKa of the
above reaction (pH6.8). Thus SLC20, which prefers H2PO4,
and SLC34, which prefers HPO42, transport most efficiently in
the acidic and alkaline ranges, respectively (Fig. 6). This
difference in preferred Pi species may explain why PFA inhib-
its Pi transport by SLC34, but not by SLC20.
The two families also differ in their substrate stoichiometry.
NaPi-IIa and NaPi-IIb transport three Na ions per transport
cycle, concomitant with the translocation of one net positive
charge, whereas NaPi-IIc only takes two Na ions, resulting in
electroneutral transport. Like NaPi-IIc also PiT transports two
Na ions per completed cycle, but because Pi is transported in
its monovalent form, net positive charge is also translocated.
These differences in stoichiometry and preferred Pi species
result in a 100-fold difference in Pi concentration capacity from
the lowest (NaPi-IIc, 100-fold) to the highest (NaPi-IIa and IIb,
10,000-fold; see Table 1). What are the physiological conse-
quences of these differences in stoichiometry? Because NaPi-
IIc transports one less Na ion (resulting in electroneutral
transport) than its electrogenic counterparts, the energetic cost
of transporting Pi is smaller. Less Na is loaded into the cell,
and less energy is needed to maintain the cell’s negative
membrane potential.
With respect to substrate binding order (Fig. 7), SLC34
proteins appear to exhibit a strict Na-Na-Pi-Na order (Fig.
7A), whereas the available evidence for SLC20 is less clear and
random Na/Pi interactions cannot be excluded (81) (Fig. 7B).
Moreover, the lack of detectable pre-steady-state currents in
SLC20 prevents assigning voltage dependence to any particu-
lar step in the transport cycle, unlike for NaPi-IIa and IIb. This
type of analysis assumes that pre-steady-state currents report
on events that are associated with significant conformational
changes related to the transport cycle; however, other scenarios
are possible that would lead to the same macroscopic behavior.
It is also conceivable that some of the pre-steady-state charge
represents a conventional gating charge that precedes channel
opening. In contrast to the canonical alternating access model,
a channel-like “hopping” model, in which substrates move
single file through a pore, successively occupying binding sites
according to availability, was proposed, whereby the salient
kinetic features of Na-coupled transport systems were pre-
dicted (92). Although several studies (40, 58) have argued
against the validity of such a scheme in its purest form, the
recent finding of a Cl channel that acts like a H/Cl antiport
(1) indicates that channels and carriers may indeed share
common mechanistic features.
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